Image 1_A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24.tif
Background<p>Chronic hepatitis B (CHB) is an infectious disease mainly affecting the liver, caused by the hepatitis B virus (HBV). In the treatment of CHB, pegylated interferon α-2b (PEG-IFNα-2b) is one of the important therapeutic options. However, there are significant individual differences...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Další autoři: | , , , , , , |
| Vydáno: |
2025
|
| Témata: | |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|